Notes

Języki Obce - Publikacje Nauczycieli
T contrasuppressor cells that reverse skin induced suppression of TH1 mediated contact sensitivity. 6. Nazimek K., Dorożyńska I., Sikora E., Bryniarski K.: Alleviation of suppression of contact sensitivity response induced by low dose treatment with cyclophosphamide. 9. sprawdzian , Sikora E., Nowak B., Ptak M., Ptak W., Bryniarski K.: Low dose of cyclophosphamide alleviates the suppression of contact sensitivity response mediated by macrophages. 1. Ciszek-Lenda M, Nowak B, Śróttek M, Górska-Frączek S, Gamian A, Marcinkiewicz J Immunoregulatory potential of Lactobacillus rhamnosus KL37 - derived exopolysaccharide (EPS). 11. Nowak B., Ciszek-Lenda M., Śróttek M., Gamian A., Górska-Frączek S. and Marcinkiewicz J.: Immunomodulatory effect of Lactobacillus rhamnosus KL37-derived exopolysaccharide on arthritis onset in DBA/1 mice in the passive transfer model of CIA. 5. Jawień J, Olszanecki R, Nowak B, Marcinkiewicz J: Apolipoprotein E - knockout mice: an experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative anti-atherogenic properties of drugs. 9. Nazimek K., Dorożyńska I, Bryniarski K.: The regulatory mechanisms of contact sensitivity response induced by low dose treatment with cyclophosphamide. 8. Bryniarski K., Nazimek K., Sikora E., Nowak B., Ptak M., Askenase P.W., Ptak W.: miRNA-150 inhibits contact sensitivity response via antigen-specific exosomes produced by T suppressor cells.

10. Filipczak-Bryniarska I., Nowak B., Sikora E., Woroń J., Majewska M., Szczepanik M., Wordliczek J., Ptak W., Bryniarski K.: The influence of opioids treatment on the humoral and contact sensitivity response in mice. 12. wypracowanie -Bryniarska I., Nowak B., Sikora E., Nazimek K., Ptak M., Woroń J., Wordliczek J., Ptak W., Bryniarski K.: The influence of opioids treatment on the immune response in mice. 10. Nazimek K, Nowak B, Ptak W, Bryniarski K. Exosomal T cell suppressor factor inhibits the generation of reactive oxygen intermediates in murine peritoneal macrophages. 6. Józefowski S, Sobota A, Hamasur B, Pawłowski A, Kwiatkowska K.: Mycobacterium tuberculosis lipoarabinomannan enhances LPS-induced TNF-α production and inhibits NO secretion by engaging scavenger receptors. 7. Nowak B, Ciszek-Lenda M, Śróttek M, Lazar A, Górska-Frączek S, Gamian A, Marcinkiewicz J. Lactobacillus rhamnosus KL-37 - derived, highly purified exopolysaccharide (EPS) inhibits adjuvant effect of LPS on the development of CIA in DBA/1 mice.

4. Nowak B., Ciszek-Lenda M., Śróttek M., Gamian A., Kontny E., Górska-Frączek S. and Marcinkiewicz J.: Lactobacillus rhamnosus exopolysaccharide ameliorates arthritis induced by the systemic injection of collagen and lipopolysaccharide in DBA/1 mice, Archivum Immunologiae et Therapiae Experimentalis 2011 (in press). 11. Sikora E., Nowak B., Nazimek K., Ptak M., Askenase P.W., Ptak W., Bryniarski K.: Structure and function of oxazolone specific T suppressor factor in contact sensitivity response. 2. Bryniarski K., Sikora E., Ptak M., Askenase P.W., Ptak W.: Exosomes produced by T suppressor cells contain srRNA to regulate contact sensitivity response. 8. Majewska-Szczepanik M., Bryniarski K., Ptak M., Marcińska K., Zemelka-Wiącek M., Lobo F., Ptak W., Szczepanik K.: Role of TLR ligands in epicutaneously induced contrasuppression. 4. Majewska-Szczepanik M., Marcińska K., Bryniarski K.,. 5. Yamamoto N., Kerfoot S., Dela Cruz C., Szczepanik M., Majewska-Szczepanik M., Bryniarski K., Philip William Askenase P.W.: Aid requirement for B-1 initiating cell igm antibodies that mediate early acquired protection from pneumococcal pneumonia: shared properties with cutaneous contact sensitivity.


T cell exosomes from tolerized mice deliver inhibitory miRNA-150 to antigen specifically suppress effector T cells. 2. Ciszek-Lenda M.: Biological functions of exopolysacharides from probiotic bacteria. 2. Prokopowicz Z. , Arce F.,Biedroń R., Chiang Ch., Ciszek M., Katz D.R., Nowakowska M., Zapotoczny S.,Marcinkiewicz J., and Chain B. : Hypochlorous Acid: Natural adjuvant that facilitates antigen processing, cross priming, and the induction of adaptive immunity. 4. Prokopowicz Z, Marcinkiewicz J, Katz DR, Chain BM.: Neutrophil Myeloperoxidase: Soldier and Statesman. 5. Marcinkiewicz J, Kontny E. Taurine and inflammatory diseases. 6. Marcinkiewicz J, Strus M, Walczewska M, Gacoń A. Are taurine haloamines (TauCl and tauBr) good candidates for the treatment of biofilm associated infections? 3. Józefowski S, Yang Z, Marcinkiewcz J , Kobzik L. :Scavenger receptors and β-glucan receptors participate in the recognition of yeasts by murine macrophages. Part 2. Contribution to recognition and phagocytosis of pathogens as well as induction of immune response. 3. Bryniarski K., Sikora E., Ptak M., Askenase P.W., Ptak W.: Structure and function of oxazolone specific T suppressor factor in contact sensitivity response.

Effects on OVA-specific humoral response. Effects on the production of inflammatory mediators by mouse macrophages. The role of macrophages. The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. Part 1. tutaj of receptors, their ligand binding repertoires and ability to initiate intracellular signaling. Ang.The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. 7. Nazimek K., Bryniarski K.: The role of macrophages in allergy and asthma. 4. Nazimek K., Bryniarski K.: Zahamowanie produkcji reaktywnych form tlenu przez mysie makrofagi otrzewnowe indukowane przez czynnik supresyjny limfocytów T natomiast jego frakcje RNA. 1. Askenase P.W., Bryniarski K.: Antigen specific exosomes: a new way to target delivery os selected siRNAs. 5. Sikora E., Bryniarski K.: Badania grupy i pracy czynnika supresyjnego charakterystycznego dla nadwrażliwości kontaktowej wywołanej przez oksazolon (OX-TsF) u myszy. 3. Filipczak-Bryniarska I., Woroń J., Bryniarski K.: Ból ośrodkowy. 5. Filipczak- Bryniarska I, Woroń J, Kleja J, Bryniarski K.: Fibromyalgia - case report.


My Website: https://opracowanienaukowe.pl/artykul/2630/podsumowanie-diagnozy-koncowej-6-latkow